SMITH TODD N
SEC insider (Form 3/4/5 filer). CIK 0001523672. Director at Latigo Biotherapeutics, Inc. (LTGO). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 6, 2026. Located in THOUSAND OAKS, CA.
Companies SMITH TODD N has filed insider reports for
- Latigo Biotherapeutics, Inc. (LTGO): Director
SMITH TODD N
CIK: 0001523672
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LTGO
Latigo Biotherapeutics, Inc.
Director